Yonatan Ganor

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Cannabidiol prevents mucosal HIV-1 transmission by targeting Langerhans cells, dendritic cells, macrophages and T-cells.

Cannabidiol prevents mucosal HIV-1 transmission by targeting Langerhans cells, dendritic cells, macrophages and T-cells.

Journal: Mucosal immunology
Published: January 05, 2026

The science at HIVR4P 2024: The era of choice in biomedical HIV prevention.

The science at HIVR4P 2024: The era of choice in biomedical HIV prevention.

Journal: Journal of the International AIDS Society
Published: March 11, 2025

Erratum for Barbosa Bomfim et al., "CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients".

Erratum for Barbosa Bomfim et al., "CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients".

Journal: Journal of virology
Published: December 10, 2024

The HUSH epigenetic repressor complex silences PML nuclear body-associated HSV-1 quiescent genomes.

The HUSH epigenetic repressor complex silences PML nuclear body-associated HSV-1 quiescent genomes.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 26, 2024

CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients.

CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients.

Journal: Journal of virology
Published: August 20, 2024

TRPV1 activation in human Langerhans cells and T cells inhibits mucosal HIV-1 infection via CGRP-dependent and independent mechanisms.

TRPV1 activation in human Langerhans cells and T cells inhibits mucosal HIV-1 infection via CGRP-dependent and independent mechanisms.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 22, 2023

Experimental Models to Study HIV Latency Reversal from Male Genital Myeloid Cells.

Experimental Models to Study HIV Latency Reversal from Male Genital Myeloid Cells.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 05, 2022

CGRP inhibits human Langerhans cells infection with HSV by differentially modulating specific HSV-1 and HSV-2 entry mechanisms.

CGRP inhibits human Langerhans cells infection with HSV by differentially modulating specific HSV-1 and HSV-2 entry mechanisms.

Journal: Mucosal immunology
Published: October 19, 2021

Native CGRP Neuropeptide and Its Stable Analogue SAX, But Not CGRP Peptide Fragments, Inhibit Mucosal HIV-1 Transmission.

Native CGRP Neuropeptide and Its Stable Analogue SAX, But Not CGRP Peptide Fragments, Inhibit Mucosal HIV-1 Transmission.

Journal: Frontiers in immunology
Published: September 29, 2021

Short Communication: Decreased Plasma Calcitonin Gene-Related Peptide as a Novel Biomarker for HIV-1 Disease Progression.

Short Communication: Decreased Plasma Calcitonin Gene-Related Peptide as a Novel Biomarker for HIV-1 Disease Progression.

Journal: AIDS research and human retroviruses
Published: November 30, 2018

HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy.

HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy.

Journal: Nature microbiology
Published: July 04, 2018

Live Imaging of HIV-1 Transfer across T Cell Virological Synapse to Epithelial Cells that Promotes Stromal Macrophage Infection.

Live Imaging of HIV-1 Transfer across T Cell Virological Synapse to Epithelial Cells that Promotes Stromal Macrophage Infection.

Journal: Cell reports
Published: October 06, 2017
Showing 1-12 of 22

Last Updated: 09/26/2026